|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Leus AJG, Haisma MS, Terra JB, Diercks
GFH, Van Kester MS, Halmos GB, Rácz E, Van Dijk BAC and Plaat BEC:
Age-related differences in tumour characteristics and prognostic
factors for disease progression in cutaneous squamous cell
carcinoma of the head and neck. Acta Derm Venereol.
102(adv00652)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Grover P, Flukes S, Jacques A, Leedman S,
Lindsay A, White R, Friedland P, Gurfinkel R and Lim AM:
Clinicopathological characteristics and clinical morbidity in
high-risk head and neck cutaneous squamous cell carcinoma patients
in Western Australia. Intern Med J. 52:944–951. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Han AY and John MAS: Predictors of nodal
metastasis in cutaneous head and neck cancers. Curr Oncol Rep.
24:1145–1152. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Grammatica A, Tomasoni M, Fior M, Ulaj E,
Gualtieri T, Bossi P, Battocchio S, Lombardi D, Deganello A,
Mattavelli D, et al: Regional disease in head and neck cutaneous
squamous cell carcinoma: The role of primary tumor characteristics
and number of nodal metastases. Eur Arch Otorhinolaryngol.
279:1573–1584. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lubov J, Labbé M, Sioufi K, Morand GB,
Hier MP, Khanna M, Sultanem K and Mlynarek AM: Prognostic factors
of head and neck cutaneous squamous cell carcinoma: A systematic
review. J Otolaryngol Head Neck Surg. 50(54)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fox M, Brown M, Golda N, Goldberg D,
Miller C, Pugliano-Mauro M, Schmults C, Shin T, Stasko T, Xu YG, et
al: Nodal staging of high-risk cutaneous squamous cell carcinoma. J
Am Acad Dermatol. 81:548–557. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Arron ST, Wysong A, Hall MA, Bailey CN,
Covington KR, Kurley SJ, Goldberg MS, Kasprzak JM, Somani AK,
Ibrahim SF, et al: Gene expression profiling for metastatic risk in
head and neck cutaneous squamous cell carcinoma. Laryngoscope
Investig Otolaryngol. 7:135–144. 2022.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Hurell MJL, Low TH, Ebranhimi A, Veness M,
Ashford B, Porceddu S and Clark JR: Evolution of head and neck
cutaneous squamous cell carcinoma nodal staging-an Australian
perspective. Cancers (Basel). 14(5101)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stewart JR, Ahn JW and Brewer JD:
In-transit metastasis of cutaneous squamous cell carcinoma with
lymphovascular invasion in an immunocompetent patient. Cureus.
14(e21204)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morosin T, Ashford B, Ranson M, Gupta R,
Clark J, Iyer NG and Spring K: Circulating tumour cells in
regionally metastatic cutaneous squamous cell carcinoma: A pilot
study. Oncotarget. 7:47111–47115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nwabudike LC and Tatu AL: Reply to
Gambichler T et al: Altered epigenetic pathways and cell
cycle dysregulation in healthy appearing skin of patients with
koebnerized squamous cell carcinomas following skin surgery. J Eur
Acad Dermatol Venereol. 33:e3–e4. 2019.
|
|
13
|
Janković I, Kovačević P, Janković D,
Stevanović G and Momčilović S: Lymphatic drainage map of the head
and neck skin squamous cell carcinoma detected by sentinel lymph
node biopsy. Eur Rev Med Pharmacol Sci. 25:5228–5234.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Waldman A and Schmults C: Cutaneous
squamous cell carcinoma. Hematol Oncol Clin North Am. 33:1–12.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Thiem DGE, Scharr K, Pabst AM, Saka B and
Kämmerer PW: Facial cutaneous squamous cell carcinoma-microscopic
safety margins and their impact on developing local recurrences. J
Craniomaxillofac Surg. 48:49–55. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hori R, Shinohara S, Kojima T, Kogoshima
H, Kitamura M, Tateya I, Tamaki H, Kumabe Y, Asato R, Harada H, et
al: Real world outcomes and prognostic factors in patients
receiving Nivolumab therapy for reccurent or metastatic head and
neck carcinoma. Cancers (Basel). 11(1317)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu MP, Sethi RKV and Emerick KS: Sentinel
lymph node biopsy for high-risk cutaneous squamous cell carcinoma
of the head and neck. Laryngoscope. 130:108–114. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hughes BGM, Munoz-Couselo E, Mortier L,
Bratland Å, Gutzmer R, Roshdy O, González Mendoza R, Schachter J,
Arance A, Grange F, et al: Pembrolizumab for locally advanced and
recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629
study): An open-label, nonrandomized, multicenter, phase II trial.
Ann Oncol. 32:1276–1285. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Baggi A, Quaglino P, Rubatto M, Depenni R,
Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris
K, et al: Real world data of cemiplimab in locally advanced and
metastatic cutaneous squamous cell carcinoma. Eur J Cancer.
157:250–258. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mei Z, Huang J, Qiao B and Lam AK: Immune
checkpoint pathways in immunotherapy for head and neck squamous
cell carcinoma. Int J Oral Sci. 12(16)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Constantino A, Canali L, Festa BM, Spriano
G, Mercante G and De Virgilio A: Sentinel lymph node biopsy in
high-risk cutaneous squamous cell carcinoma of the head and neck:
Systematic review and meta-analysis. Head Neck. 44:2288–2300.
2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Labani-Motlagh A, Ashja-Mahdavi M and
Loskog A: The tumor microenvironment: A milieu hindering and
obstructing antitumor immune responses. Front Immunol.
11(940)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen A, Ali N, Boasberg P and Ho AS:
Clinical remission of cutaneous squamous cell carcinoma of the
auricle with cetuximab and nivolumab. J Clin Med.
7(10)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Thornton AM, Piccirillo CA and Shevach EM:
Activation requirements for the induction of CD4+CD25+ T cell
suppressor function. Eur J Immunol. 34:366–76. 2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Harrell CR, Simovic Markovic B, Fellabaum
C, Arsenijevic A, Djonov V and Volarevic V: Molecular mechanisms
underlying therapeutic potential of pericytes. J Biomed Sci.
25(21)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Coughlin SS and Dean LT: Cancer
survivorship care plans, financial toxicity, and financial planning
alleviating financial distress among cancer survivors. Support Care
Cancer. 27:1969–1971. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ezzedine K, Painchault C and Brignone M:
Use of complete clearance for assessing treatment efficacy for
5-fluorouracil interventions in actinic keratoses: How baseline
lesion count can impact this outcome. J Mark Access Health Policy.
8(1829884)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bortoluzzi P, Brambilla R, Berti E,
Marzano AV and Piccinno R: The role of radiotherapy in the
management of cutaneous squamous cell carcinoma: A retrospective
study on 92 cases. Ital Dermatol Venereol. 157:363–367.
2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
McDowell L and Yom S: Locally advanced
non-melanomatous skin cancer: Contemporary radiotherapeutic
management. Oral Oncol. 99(104443)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hazim AZ, Reed CT, Price KA, Foote RL, Ma
DJ, Neben-Wittich M, DeLone DR, Jenkins SM, Smith CY and
Chintakuntlawar AV: Survival outcomes in locally advanced cutaneous
squamous cell carcinoma presenting with clinical perineural
invasion alone. Head Neck. 43:1995–2001. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Schachtel MJC, Gandhi M, Bowman JJ,
Porceddu SV and Panizza BJ: Facial nerve perineural spread from
cutaneous squamous cell carcinoma of the head and neck: A single
institution analysis of epidemiology, treatment, survival outcomes,
and prognostic factors. Head Neck. 44:1223–1236. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jackson JE, Dickie GJ, Wiltshire KL,
Keller J, Tripcony L, Poulsen MG, Hughes M, Allison RW and Martin
JM: Radiotherapy for perineural invasion in cutaneous head and neck
carcinomas: Toward a risk-adapted treatment approach. Head Neck.
31:604–610. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Amit M, Liu C, Mansour J, Gleber-Netto FO,
Tam S, Baruch EN, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI,
et al: Elective neck dissection versus observation in patients with
head and neck cutaneous squamous cell carcinoma. Cancer.
127:4413–4420. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lin C, Ballah T, Nottage M, Hay K, Chua B,
Kenny L, Thomas P, Teng M, Keller J, Le T, et al: A prospective
study investigating the efficacy and toxicity of definitive
ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or
regionally advanced unresectable cutaneous squamous cell carcinoma.
Radiat Oncol. 16(69)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dikova V, Jantus-Lewintre E and Bagan J:
Potential non-invasive biomarkers for early diagnosis of oral
squamous cell carcinoma. J Clin Med. 10(1658)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Villa A, Celentano A, Glurich I, Borgnakke
WS, Jensen SB, Peterson DE, Delli K, Ojeda D, Vissink A and Farah
CS: World workshop on oral medicine VII: Prognostic biomarkers in
oral leukoplakia: A systematic review of longitudinal studies. Oral
Dis. 25 (Suppl 1):S64–S78. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Assao A, Domingues MAC, Minicucci EM,
Marchi FA, Coutinho-Camillo CM and Oliveira DT: The relevance of
miRNAs as promising biomarkers in lip cancer. Clin Oral Investig.
25:4591–4598. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Panarese I, Aquino G, Ronchi A, Longo F,
Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M and
Franco R: Oral and Oropharyngeal squamous cell carcinoma:
Prognostic and predictive parameters in the etiopathogenetic route.
Expert Rev Anticancer Ther. 19:105–119. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wilkat M, Bast H, Drees R, Dünser J, Mahr
A, Azoitei N, Marienfeld R, Frank F, Brhel M, Ushmorov A, et al:
Adenosine receptor 2B activity promotes autonomous growth,
migration as well as vascularization of head and neck squamous cell
carcinoma cells. Int J Cancer. 147:202–217. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu SC, Wu YC, Huang CM, Hsieh MS, Huang
TY, Huang CS, Hsu TN, Huang MS, Lee WH, Yeh CT and Lin CS:
Inhibition of Bruton's tyrosine kinase as a therapeutic strategy
for chemoresistant oral squamous cell carcinoma and potential
suppression of cancer stemness. Oncogenesis. 10(20)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Alsahafi E, Begg K, Amelio I, Raulf N,
Lucarelli P, Sauter T and Tavassoli M: Clinical update on head and
neck cancer: Molecular biology and ongoing challenges. Cell Death
Dis. 10(540)2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Grassilli E, Cerrito MG, Bonomo S,
Giovannoni R, Conconi D and Lavitrano M: p65BTK is a novel
biomarker and therapeutic target in solid tumors. Front Cell Dev
Biol. 9(690365)2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6(92)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ngan HL, Liu Y, Fong AY, Poon PHY, Yeung
CK, Chan SSM, Lau A, Piao W, Li H, Tse JSW, et al: MAPK pathway
mutations in head and neck cancer affect immune microenvironments
and ErbB3 signaling. Life Sci Alliance.
3(e201900545)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wilbur J: Surveillance of the adult cancer
survivor. Am Fam Physician. 91:29–36. 2015.PubMed/NCBI
|
|
47
|
Kriegs M, Clauditz TS, Hoffer K, Bartels
J, Buhs S, Gerull H, Zech HB, Bußmann L, Struve N, Rieckmann T, et
al: Analyzing expression and phosphorylation of the EGF receptor in
HNSCC. Sci Rep. 9(13564)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lee A, Duggan S and Deeks ED: Cemiplimab:
A review in advanced cutaneous squamous cell carcinoma. Drugs.
80:813–819. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ilmonen S, Sollamo E, Juteau S and
Koljonen V: Sentinel lymph node biopsy in high-risk cutaneous
squamous cell carcinoma of the head and neck. J Plast Reconstr
Aesthet Surg. 75:210–216. 2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Maubec E, Boubaya M, Petrow P,
Beylot-Barry M, Basset-Seguin N, Deschamps L, Grob JJ, Dréno B,
Scheer-Senyarich I, Bloch-Queyrat C, et al: Phase II study of
pembrolizumab as first-line, single-drug therapy for patients with
unresectable cutaneous squamous cell carcinomas. J Clin Oncol.
38:3051–3061. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Luk PP, Ebrahimi A, Veness MJ, McDowell L,
Magarey M, Gao K, Palme CE, Clark JR and Gupta R: Prognostic value
of the 8th edition American joint commission cancer nodal staging
system for patients with head and neck cutaneous squamous cell
carcinoma: A multi-institutional study. Head Neck. 43:558–567.
2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Schmidt C, Martin JM, Khoo E, Plank A and
Grigg R: Outcomes of nodal metastatic cutaneous squamous cell
carcinoma of the head and neck treated in a regional center. Head
Neck. 37:1808–1815. 2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hahlweg P, Hoffmann J, Härter M, Frosch
DL, Elwyn G and Scholl I: In absentia: An exploratory study of how
patients are considered in multidisciplinary cancer team meetings.
PLoS One. 10(e0139921)2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Robinson TE, Janssen A, Harnett P, Museth
KE, Provan PJ, Hills DJ and Shaw T: Embedding continuous quality
improvement processes in multidisciplinary teams in cancer care:
Exploring the boundaries between quality and implementation
science. Aust Health Rev. 41:291–296. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Hoesseini A, Dronkers EAC, Sewnaik A,
Hardillo JAU, Baatenburg de Jong RJ and Offerman MPJ: Head and neck
cancer patients' preferences for individualized prognostic
information: A focus group study. BMC Cancer.
20(399)2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Szturz P and Vermorken JB: Management of
recurrent and metastatic oral cavity cancer: Raising the bar a step
higher. Oral Oncol. 101(104492)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Bruni D, Angell HK and Galon J: The immune
contexture and Immunoscore in cancer prognosis and therapeutic
efficacy. Nat Rev Cancer. 20:662–680. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ziemann F, Arenz A, Preising S, Wittekindt
C, Klussmann JP, Engenhart-Cabillic R and Wittig A: Increased
sensitivity of HPV-positive head and neck cancer cell lines to
x-irradiation ± cisplatin due to decreased expression of E6 and E7
oncoproteins and enhanced apoptosis. Am J Cancer Res. 5:1017–1031.
2015.PubMed/NCBI
|
|
59
|
Chen YP, Wang YQ, Lv JW, Li YQ, Chua MLK,
Le QT, Lee N, Colevas AD, Seiwert T, Hayes DN, et al:
Identification and validation of novel microenvironment-based
immune molecular subgroups of head and neck squamous cell
carcinoma: Implications for immunotherapy. Ann Oncol. 31:316–318.
2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ji H and Zhou Z: A ‘Hybrid’ radiotherapy
regimen designed for immunomodulation: Combining high-dose
radiotherapy with low-dose radiotherapy. Cancers (Basel).
14(3505)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Patil VM, Singh GK, Noronha V, Joshi A,
Menon N, Lashkar SG, Mathrudev V, Satam KN, Mukadam SA and Prabhash
K: Lymphopenia during chemoradiation-Foe or friend.
Ecancermedicalscience. 14(1109)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Köcher S, Zech HB, Krug L, Gatzemeier F,
Christiansen S, Meyer F, Rietow R, Struve N, Mansour WY, Kriegs M,
et al: A lack of effectiveness in the ATM-orchestrated DNA damage
response contributes to the DNA repair defect of hpv-positive head
and neck cancer cells. Front Oncol. 12(765968)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Brancaccio G, Briatico G, Pellegrini C,
Rocco T, Moscarella E and Fargnoli MC: Risk factors and diagnosis
of advanced cutaneous squamous cell carcinoma. Dermatol Pract
Concept. 11 (Suppl 2)(e2021166S)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Skulsky SL, O'Sullivan B, McArdle O,
Leader M, Roche M, Conlon PJ and O'Neill JP: Review of high-risk
features of cutaneous squamous cell carcinoma and discrepancies
between the American joint committee on cancer and NCCN clinical
practice guidelines in oncology. Head Neck. 39:578–594.
2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chen SY, Chen QW, Shou LM, Pan H, Ruan SM,
Liang ZH and Shu QJ: Stevens-Johnson syndrome/toxic epidermal
necrolysis successfully treated with Chinese herbal medicine
Pi-Yan-Ning: A case report. J Integr Med. 19:555–560.
2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu Y, Tang J, Yu LY and Jiang Q:
Successful treatment of immune-related lichenoid dermatitis by
Weiling decoction in a patient with non-small cell lung cancer: A
case report and review of literature. Explore (NY). 19:730–735.
2023.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Luo B, Que ZJ, Zhou ZY, Wang Q, Dong CS,
Jiang Y, Hu B, Shi H, Jin Y, Liu JW, et al: Feiji Recipe inhibits
the growth of lung cancer by modulating T-cell immunity through
indoleamine-2,3-dioxygenase pathway in an orthotopic implantation
model. J Integr Med. 16:283–289. 2018.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Flezar MS, Prevodnik VK, Kirbis IS and
Strojan P: Cutaneous squamous cell carcinoma metastatic to chronic
lymphocytic leukaemia: Diagnostic potential of fine needle
aspiration cytology. Cytopathology. 17:288–294. 2006.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Künzel J, Brandenstein M, Zeman F, Symeou
L, Platz Batista da Silva N and Jung EM: Multiparametric ultrasound
of cervical lymph node metastases in head and neck cancer for
planning non-surgical therapy. Diagnostics (Basel).
12(1842)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Rossi SH, Prezzi D, Kelly-Morland C and
Goh V: Imaging for the diagnosis and response assessment of renal
tumours. World J Urol. 36:1927–1942. 2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Machiels JP, Rene Leemans C, Golusinski W,
Grau C, Licitra L and Gregoire V: EHNS Executive Board. Electronic
address: simplesecretariat@ehns.org,
ESMO Guidelines Committee. Electronic address: simpleclinicalguidelines@esmo.org,
ESTRO Executive Board. Electronic address: simpleinfo@estro.org. Squamous
cell carcinoma of the oral cavity, larynx, oropharynx and
hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 31:1462–1475.
2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Vos JL, Elbers JBW, Krijgsman O, Traets
JJH, Qiao X, van der Leun AM, Lubeck Y, Seignette IM, Smit LA,
Willems SM, et al: Neoadjuvant immunotherapy with nivolumab and
ipilimumab induces major pathological responses in patients with
head and neck squamous cell carcinoma. Nat Commun.
12(7348)2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Khadela A, Shah Y, Mistry P, Bodiwala K
and Cb A: Immunomodulatory therapy in head and neck squamous cell
carcinoma: Recent advances and clinical prospects. Technol Cancer
Res Treat. 22(15330338221150559)2023.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Petit C, Lacas B, Pignon JP, Le QT,
Grégoiere V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW,
et al: Chemotherapy and radiotherapy in locally advanced head and
neck cancer: An individual patient data network meta-analysis.
Lancet Oncol. 22:727–736. 2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Newman JG, Hall MA, Kurley SJ, Cook RW,
Farberg AS, Geiger JL and Koyfman SA: Adjuvant therapy for
high-risk cutaneous squamous cell carcinoma: 10-Year review. Head
Neck. 43:2822–2843. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Svajdova M, Dubinsky P and Kazda T:
Radical external beam re-irradiation in the treatment of recurrent
head and neck cancer: Critical review. Head Neck. 43:354–366.
2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Uppaluri R, Campbell KM, Egloff AM,
Zolkind P, Skidmore ZL, Nussenbaum B, Paniello RC, Rich JT, Jackson
R, Pipkorn P, et al: Neoadjuvant and adjuvant pembrolizumab in
resectable locally advanced, human papillomavirus-unrelated head
and neck cancer: A multicenter, phase II trial. Clin Cancer Res.
26:5140–5152. 2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ng SP, Pollard C III, Kamal M, Ayoub Z,
Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, et al:
Risk of second primary malignancies in head and neck cancer
patients treated with definitive radiotherapy. NPJ Precis Oncol.
3(22)2019.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lideståhl A, Johansson G, Siegbahn A and
Lind PA: Estimated risk of radiation-induced cancer after thymoma
treatments with proton- or X-ray beams. Cancers (Basel).
13(5153)2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Ordoñez R, Otero A, Jerez I, Medina JA,
Lupiañez-Pérez Y and Gomez-Millan J: Role of radiotherapy in the
treatment of metastatic head and neck cancer. Onco Targets Ther.
12:677–683. 2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Zhang S, Zeng N, Yang J, He J, Zhu F, Liao
W, Xiong M and Li Y: Advancements of radiotherapy for recurrent
head and neck cancer in modern era. Radiat Oncol.
18(166)2023.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Runnels J, Bloom JR, Hsieh K, Dickstein
DR, Shi Y, Jones BM, Lehrer EJ and Bakst RL: Combining radiotherapy
and immunotherapy in head and neck cancer. Biomedicines.
11(2097)2023.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Fang LC, Lemos B, Douglas J, Iyer J and
Nghiem P: Radiation monotherapy as regional treatment for lymph
node-positive Merkel cell carcinoma. Cancer. 116:1783–1790.
2010.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wahlberg P, Anderson H, Biörklund A,
Möller T and Perfekt R: Carcinoma of the parotid and submandibular
glands-a study of survival in 2465 patients. Oral Oncol.
38:706–713. 2002.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Reichelmann H, Dejaco D, Steinbichler TB,
Lettenbich-Haug A, Anegg M, Ganswindt U, Gamerith G and Riedl D:
Functional outcomes in head and neck cancer patients. Cancers
(Basel). 14(2135)2022.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Henry M, Harvey R, Chen LM, Meaney M,
Nguyen TTT, Kao HT, Rosberger Z, Frenkiel S, Hier M, Zeitouni A, et
al: Genetic predisposition to depression and inflammation impacts
symptom burden and survival in patients with head and neck cancer:
A longitudinal study. J Affect Disord. 331:149–157. 2023.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ch'ng S, Low I, Ng D, Brasch H, Sullivan
M, Davis P and Tan ST: Epidermal growth factor receptor: A novel
biomarker for aggressive head and neck cutaneous squamous cell
carcinoma. Hum Pathol. 39:344–349. 2008.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Bachar G, Mizrachi A, Rabinovics N,
Guttman D, Shpitzer T, Ad-El D and Hadar T: Prognostic factors in
metastatic cutaneous squamous cell carcinoma of the head and neck.
Ear Nose Throat J. 95:E32–E36. 2016.PubMed/NCBI
|
|
89
|
Sood A, Wykes J, Roshan D, Wang LY,
McGuinness J, Fowler A and Ebrahimi A: A critical analysis of the
prognostic performance of the 8th edition American joint committee
on cancer staging for metastatic cutaneous squamous cell carcinoma
of the head and neck. Head Neck. 41:1591–1596. 2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Bossi P, Alfieri S, Strojan P, Takes RP,
López F, Mäkitie A, Saba NF, Rodrigo JP, Bradford C, Suarez C, et
al: Prognostic and predictive factors in recurrent and/or
metastatic head and neck squamous cell carcinoma: A review of the
literature. Crit Rev Oncol Hematol. 137:84–91. 2019.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Thomson AK, Kelley BF, Prokop LJ, Murad MH
and Baum CL: Risk factors for cutaneous squamous cell carcinoma
recurrence, metastasis, and disease-specific death: A systematic
review and meta-analysis. JAMA Dermatol. 152:419–428.
2016.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Wermker K, Kluwig J, Schipmann S, Klein M,
Schulze HJ and Hallermann C: Prediction score for lymph node
metastasis from cutaneous squamous cell carcinoma of the external
ear. Eur J Surg Oncol. 41:128–135. 2015.PubMed/NCBI View Article : Google Scholar
|
|
93
|
National Library of Medicine: RM-1995
Photoimmunotherapy, as monotherapy or combined with pembrolizumab,
in patients with advanced CuSCC and HNSCC. ClinicalTrials.gov ID: NCT05220748. https://clinicaltrials.gov/study/NCT05220748.
Accessed April 19, 2023.
|
|
94
|
An open-label study using ASP-1929
photoimmunotherapy in combination with anti-PD1 therapy in EGRF
expressing advanced solid tumors, 2024. https://www.clinicaltrials.gov/study/NCT04305795.
|
|
95
|
Volovat SR, Ursulescu CL, Moisii LG,
Volovat C, Boboc D, Scripcariu D, Amurariti F, Stefanescu C,
Stolniceanu CR, Agop M, et al: The landscape of nanovectors for
modulation in cancer immunotherapy. Pharmaceutics.
14(397)2022.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Economopoulou P, de Bree R, Kotsantis I
and Psyrri A: Diagnostic tumor markers in head and neck squamous
cell carcinoma (HNSCC) in the clinical setting. Front Oncol.
9(827)2019.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Rolih V, Barutello G, Iussich S, De Maria
R, Quaglino E, Buracco P, Cavallo F and Riccardo F: CSPG4: A
prototype oncoantigen for translational immunotherapy studies. J
Transl Med. 15(151)2017.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Green A and Olsen C: Cutaneous squamous
cell carcinoma. An epidemiological review. Br J Dermatol.
177:373–381. 2017.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Warta R, Herold-Mende C, Chaisaingmongkol
J, Popanda O, Mock A, Mogler C, Osswald F, Herpel E, Küstner S,
Eckstein V, et al: Reduced promoter methylation and increased
expression of CSPG4 negatively influences survival of HNSCC
patients. Int J Cancer. 135:2727–2734. 2014.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Goldie SJ, Cottle DL, Tan FH, Roslan S,
Srivastava S, Brady R, Partridge DD, Auden A, Smyth IM, Jane SM, et
al: Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte
proliferation in the epidermis. Cell Death Dis.
9(1072)2018.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Chahal HS, Lin Y, Ransohoff KJ, Hinds DA,
Wu W, Dai HJ, Qureshi AA, Li WQ, Kraft P, Tang JY, et al:
Genome-wide association study identifies novel susceptibility loci
for cutaneous squamous cell carcinoma. Nat Commun.
7(12048)2016.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Sánchez-Danés A, Hannezo E, Larsimont JC,
Liagre M, Youssef KK, Simons BD and Blanpain C: Defining the clonal
dynamics leading to mouse skin tumour initiation. Nature.
536:298–303. 2016.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Darido C, Georgy SR, Cullinane C, Patridge
DD, Walker R, Srivastava S, Roslan S, Carpinelli MR, Dworkin S,
Pearson RB and Jane SM: Stage-dependent therapeutic efficacy in
PI3K/mTOR-driven squamous cell carcinoma of the skin. Cell Death
Differ. 25:1146–1159. 2018.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Majumdar M, Vouri K and Stallcup WB:
Engagement of the NG2 proteoglycan triggers cell spreading via rac
and p130cas. Cell Signal. 15:79–84. 2003.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Sardone F, Santi S, Tagliavini F, Traina
F, Merlini L, Squarzoni S, Cescon M, Wagener R, Maraldi NM, Bonaldo
P, et al: Collagen VI-NG2 axis in human tendon fibroblasts under
conditions mimicking injury response. Matrix Biol. 55:90–105.
2016.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Liu N, Matsumura H, Kato T, Ichinose S,
Takada A, Namiki T, Asakawa K, Morinaga H, Mohri Y, De Arcangelis
A, et al: Stem cell competition orchestrates skin homeostasis and
ageing. Nature. 568:344–350. 2019.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Nishihara T, Remacle AG, Angert M,
Shubayev I, Shyryaev SA, Liu H, Dolkas J, Chernov AV, Strongin AY
and Shubayev VI: Matrix metalloproteinase-14 both sheds cell
surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages
and governs the response to peripheral nerve injury. J Biol Chem.
290:3693–3707. 2015.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Beckham TH, Leeman JE, Xie P, Li X,
Goldman DA, Zhang Z, Sherman E, McBride S, Riaz N, Lee N and Tsai
CJ: Long-term survival in patients with metastatic head and neck
squamous cell carcinoma treated with metastasis-directed therapy.
Br J Cancer. 121:897–903. 2019.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Lenouvel D, González-Moles MÁ, Talbaoui A,
Ramos-García P, González-Ruiz L, Ruiz-Ávila I and Gil-Montoya JA:
An update of knowledge on PD-L1 in head and neck cancers:
Physiologic, prognostic and therapeutic perspectives. Oral Dis.
26:511–526. 2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Chen HM, Wang L and Zhou SB: Recent
progress in shape memory polymers for biomedical applications. Chin
J Polym Sci. 36:905–917. 2018.
|
|
111
|
Bakst RL, Glastonbury CM, Parvathaneni U,
Katabi N, Hu KS and Yom SS: Perineural invasion and perineural
tumor spread in head and neck cancer. Int J Radiat Oncol Biol Phys.
103:1109–1124. 2019.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Das R, Langou S, Le TT, Prasad P, Lin F
and Nguyen TD: Electrical stimulation for immune modulation in
cancer treatments. Front Bioeng Biotechnol.
9(795300)2022.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Campana LG, Miklavčič D, Bertino G,
Marconato R, Valpione S, Imarisio I, Dieci MV, Granziera E, Cemazar
M, Alaibac M and Sersa G: Electrochemotherapy of superficial
tumors-current status: Basic principles, operating procedures,
shared indicators, and emerging applications. Semin Oncol.
46:173–191. 2019.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Plaschke CC, Gehl L, Johannesen HH,
Fishcher BM, Kjaer A, Lomholt AF and Wessel I: Calcium
electroporation for recurrent head and neck cancer: A clinical
phase I study. Laryngoscope Investig Otolaryngol. 4:49–56.
2019.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Caracciolo G: Clinically approved
liposomal nanomedicines: Lessons learned from the biomolecular
corona. Nanoscale. 10:4167–4172. 2018.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Ahmad S, Idris RAM, Hanaffi WNW, Perumal
K, Boer JC, Plebanski M, Jaafar J, Lim JK and Mohamud R: Cancer
nanomedicine and immune system-interactions and challenges. Front
Nanotechnol. 3(681305)2021.
|
|
117
|
Ochoa MC, Minute L, Rodriguez I, Garasa S,
Perez-Ruiz E, Inogés S, Melero I and Berraondo P:
Antibody-dependent cell cytotoxicity: Immunotherapy strategies
enhancing effector NK cells. Immunol Cell Biol. 95:347–355.
2017.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Niculet E, Bobeica C, Onisor C, Gurau G,
Nechita A, Radaschin DS, Tutunaru D, Bujoreanu-Bezman L and Tatu
AL: Basal cell carcinoma perineural invasion and suggestive signs
of perineural invasion-findings and perspectives. Life (Basel).
13(1406)2023.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Rehmani HS and Issaeva N: EGFR in head and
neck squamous cell carcinoma: Exploring possibilities of novel drug
combinations. Ann Transl Med. 8(813)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Wise-draper TM, Bahig H, Tonneau M,
Karived V and Burtness B: Current therapy for metastatic head and
neck cancer: Evidence, opportunities, and challenges. Am Soc Clin
Oncol Educ Book. 42:1–14. 2022.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Hepp MV, Eigentler TK, Kähler KC, Herbst
RA, Göppner D, Gambichler T, Ulrich J, Dippel E, Loquai C, Schell
B, et al: Immune checkpoint blockade with concurrent
electrochemotherapy in advanced melanoma: A retrospective
multicenter analysis. Cancer Immunol Immunother. 65:951–959.
2016.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Caramazza L, Nardoni M, De Angelis A,
Paolicelli P, Liberti M, Apollonio F and Petralito S:
Proof-of-concept of electrical activation of liposome nanocarries:
From dry to wet experiments. Front Bioeng Biotechnol.
8(819)2020.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Parmar K, Mohamed A, Vaish E, Thawani R,
Cetnar J and Thein KZ: Immunotherapy in head and neck squamous cell
carcinoma: An updated review. Cancer Treat Res Commun.
33(100649)2022.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Study of Cemiplimab in patients with type
of skin cancer stage II to IV cutaneous squamous cell carcinoma,
2023. https://www.clinicaltrials.gov./study/NCT04154943.
|
|
125
|
National Library of Medicine: Neoadjuvant
Cemiplimab for the treatment of resectable NSCLC, HCC, and HNSCC in
adult patients. ClinicalTrials.gov ID: NCT03916627.
https://clinicaltrials.gov/study/NCT03916627.
Accessed May 31, 2023.
|
|
126
|
National Library of Medicine: Study of
adjuvant Cemiplimab versus placebo after surgery and radiation
therapy in patients with high risk cutaneous squamous cell
carcinoma. ClinicalTrials.gov ID: NCT03969004.
https://clinicaltrials.gov/study/NCT03969004.
Accessed May 31, 2019.
|
|
127
|
National Library of Medicine:
Pembrolizumab (MK3475) versus placebo following surgery and
radiation in participants with locally advanced cutaneous squamous
cell carcinoma (MK-3475-630/KEYNOTE-630). ClinicalTrials.gov ID: NCT03833167. https://clinicaltrials.gov/study/NCT03833167.
Accessed Febryary 6, 2019.
|
|
128
|
Rades D, Zwaan I, Soror T, Idel C, Pries
R, Bruchhage KL, Hakim SG and Yu NY: Chemoradiation with cisplatin
vs carboplatin for squamous cell carcinoma of the head and neck
(SCCHN). Cancers (Basel). 15(3278)2023.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Kurosaki T, Mitani S, Tanaka K, Suzuki S,
Kanemura H, Haratani K, Fumita S, Iwasa T, Hayashi H, Yoshida T, et
al: Safety and efficacy of cetuximab-containing chemotherapy after
immune checkpoint inhibitors for patients with squamous cell
carcinoma of the head and neck: # single-center retrospective
study. Anticancer Drugs. 32:95–101. 2021.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Chen YH, Tsai CH, Chen YY, Wang JH, Hung
CH and Kuo YH: Real-world comparison of pembrolizumab and nivolumab
in advanced hepatocellular carcinoma. BMC Cancer.
23(810)2023.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Nottage MK, Lin C, Hughes BGM, Kenny L,
Smith DD, Houston K and Francesconi A: Prospective study of
definitive chemoradiation in locally or regionally advanced
squamous cell carcinoma of the skin. Head Neck. 39:679–683.
2017.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Cowey CL, Robert NJ, Espirito JL, Davis K,
Frytak J, Lowy I and Fury MG: Clinical outcomes among unresectable,
locally advanced, and metastatic cutaneous squamous cell carcinoma
patients treated with systemic therapy. Cancer Med. 9:7381–7387.
2020.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Lavaud J, Blom A, Longvert C, Magali F,
Funck-Brentano E and Saiag P: Pembrolizumab and concurrent
hypo-fractionated radiotherapy for advanced non-resectable
cutaneous squamous cell carcinoma. Eur J Dermatol. 29:636–640.
2019.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Fan M, Kang JJ, Lee A, Fan D, Wang H,
Kitpanit S, Fox P, Sine K, Mah D, McBride S, et al: Outcomes and
toxicities of definitive radiotherapy and reirradiation using
3-dimensional conformal or intensity-modulated (pencil beam) proton
therapy for patients with nasal cavity and paranasal sinus
malignancies. Cancer. 126:1905–1916. 2020.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Ogata D, Namikawa K, Otsuka M, Asai J,
Kato H, Yasuda M, Maekawa T, Fujimura T, Kato J, Takenouchi T, et
al: Systemic treatment of patients with advanced cutaneous squamous
cell carcinoma: Response rates and outcomes of the regimes used.
Eur J Cancer. 127:108–117. 2020.PubMed/NCBI View Article : Google Scholar
|
|
136
|
De Felice F, Musio D, De Falco D, Grapulin
L, Magnante AL, Caiazzo R, Bulzonetti N and Tombolini V: Definitive
weekly hypofractionated radiotherapy in cutaneous squamous cell
carcinoma: Response rates and outcomes in elderly patients unfit
for surgery. Int J Dermatol. 61:911–915. 2022.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Voruganti IS, Poon I, Husain ZA, Bayley A,
Barnes EA, Zhang L, Chin L, Erler D, Higgins K, Enepekides D, et
al: Stereotactic body radiotherapy for head and neck skin cancer.
Radiother Oncol. 165:1–7. 2021.PubMed/NCBI View Article : Google Scholar
|
